Analyst upgrades, downgrades and initiations: AXP, CAT, BMY, GNK, TXCO ...


Analyst upgrades:
  • Societe Generale upgraded shares of Veolia Environment (NYSE: VE) to Buy from Hold as they believe the company's new finance chief implement additional cost savings.
  • Citigroup upgraded shares of Sun Healthcare (NASDAQ: SUNH) to Buy from Hold and added the stock to their Top Picks Live List as they believe the market is pricing in a more severe Medicaid and Medicare reimbursement outlook than is probable. The firm has a $14 target on the stock.
  • Calyon believes in 2010, American Express (NYSE: AXP) will have easy comps, reserve releases, and income statement leverage. The firm upgraded shares to Outperform from Underperform.
  • Societe Generale (OTC: SCGLY) was upgraded to Buy from Hold at Citigroup.
  • Caterpillar (NYSE: CAT) was raised to neutral from Sell at UBS.
  • Goldman upgraded Biogen Idec (NASDAQ: BIIB) to Buy from Neutral and added shares to the Conviction Buy List; Goldman also added Bristol-Myers (NYSE: BMY) to the Conviction Buy List.
Analyst downgrades:
  • Thomas Weisel lowered BTU International (NASDAQ: BTUI) to Market Weight from Overweight due to the sharp decline in both the solar and semi markets.
  • Oppenheimer cut Genco (NYSE: GNK) to Perform from Outperform after the company eliminated its dividend as they expect several weeks of share underperformance.
  • Friedman Billings downgraded Torchmark (NYSE: TMK) to Market Perform from Outperform to reflect increased credit and rating agency risks. The firm has a $30 target on the stock.
  • Layne Christensen (NASDAQ: LAYN) was lowered to Sell from Neutral at UBS.
  • Weatherford (NYSE: WFT) was downgraded at Calyon to Outperform from Buy.
  • Digital River (NASDAQ: DRIV) was cut to Sell from Hold at Collins Stewart.
Analyst initiations:
  • ThinkEquity said Human Genome's (NASDAQ: HGSI) Albuferon will arrive to the market late and believes its LymphoStat-B will fail this summer. The firm started shares with a Sell rating and $1.50 target.
  • Cantor initiated Deltek (NASDAQ: PROJ) with a Buy rating and $6 target. The firm believes the current earnings multiple discount level is overdone and thinks shares could benefit from renewed momentum in the construction industry.
  • Johnson Rice believes TXCO Resources (NASDAQ: TXCO) will face funding gaps in 2009 and 2010, which will decide the pace of drilling programs. Shares were assumed with an Equal Weight rating.
  • Reed Elsevier (NYSE: RUK) was initiated at Jefferies with an Underperform rating.
  • Adtran (NASDAQ: ADTN) was started with an Equal Weight rating and $15 target at Barclays.
  • Community Health (NYSE: CYH) was initiated with an Outperform rating and $24 target at RBC Capital.
Symbol Lookup
IndexesChangePrice
DJIA-111.8612,778.60
NASDAQ-17.672,909.56
S&P 500-9.591,342.36

Last updated: February 10, 2012: 01:22 PM

Hot Stocks

General Electric

18.905-0.225(-1.18)

Alcoa

10.325-0.315(-2.96)

Apple Inc

494.81+1.64(+0.33)

Google Inc 'A'

606.855-4.605(-0.75)

Bank of America

8.095-0.085(-1.04)

Wal-Mart Stores

61.50-0.46(-0.74)

Exxon Mobil Corp

83.73-1.15(-1.35)

Ford

12.41-0.28(-2.21)

Citigroup

32.92-0.74(-2.20)

IBM

191.84-1.29(-0.67)

Yahoo

16.255+0.255(+1.59)

Starbucks

48.89-0.31(-0.63)

Microsoft

30.575-0.195(-0.63)

Home Depot

45.265-0.005(-0.01)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328898121480 ms.